The natural killer cell - Friend or foe in autoimmune disease?

Scandinavian Journal of Immunology

Volumn 55, Issue 5, 2002, Pages 432-441

  Flodstrom M ^a   Shi, F D ^a   Sarvetnick, N ^a   Ljunggren, H G ^b,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DAMAGE; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE PREDISPOSITION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; MICROBIAL IMMUNITY; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY; VIRUS INFECTION;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; MICE;

EID: 0036243501     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01084.x     Document Type: Review

References (168)

1. Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity
2. Autoreactivity, dynamic tuning and selectivity
3. Self-tolerance and the composition of T cell repertoire
4. Regulatory T cells in the control of immune pathology
5. Autoimmune diseases
6. The genetics of complex autoimmune diseases: Non-MHC susceptibility genes
7. Non-genetic risk determinants of type 1 diabetes
8. Environmental factors in the pathogenesis of type 1 diabetes mellitus
9. Viruses, host responses, and autoimmunity
10. Viruses as triggers of autoimmunity: Facts and fantasies
11. Antigenic mimicry, clonal selection and autoimmunity
12. Can virus infections trigger autoimmune disease?
13. Multiple pathways to induction of virus-induced autoimmune demyelination: Lessons from Theiler's virus infection
14. Virus-induced autoimmunity: Epitope spreading to myelin auto-epitopes in Theiler's virus infection of the central nervous system
15. Hepatitis C and D, retroviruses and autoimmune manifestations
16. Sleeping with the enemy - Endogenous superantigens in humans
17. Role of antigen-presenting cells in mediating tolerance and autoimmunity
18. Autoimmunity through infection or immunization?
19. Innate immunity and autoimmunity: From self-protection to self-destruction
20. The instructive role of innate immunity in the acquired immune response
21. Innate pathways that control acquired immunity
22. Innate immunity: Impact on the adaptive immune response
23. Linkages of innate and adaptive immunity
24. Biology of natural killer cells
25. NK cells and NKT cells in innate defense against viral infections
26. The biology of human natural killer-cell subsets
27. Natural killer cells and natural killer T cells
28. The biology of natural killer cells in cancer, infection, and pregnancy
29. NK cell proliferation and inflammation
30. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
31. Perforin, killer cells and gene transfer immunotherapy for cancer
32. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
33. Specific and nonspecific NK cell activation during virus infection
34. Natural killer cell activity of mononuclear cells from rheumatoid patients measured by a conjugate-binding cytotoxicity assay
35. The tissue architecture of synovial membranes in inflammatory and noninflammatory joint diseases. II. The localization of mononuclear cells as detected by monoclonal antibodies directed against T-lymphocyte subsets and natural killer cells
36. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue
37. Characterization and distribution of lymphocyte sub-populations in multiple sclerosis plaques versus autoimmune demyelinating lesions
38. Dysfunction of natural killer cells in multiple sclerosis: A possible pathogenetic factor
39. Natural killer cell activity in patients with multiple sclerosis: Interferon and plasmapheresis
40. Natural killer cell number and activity in multiple sclerosis
41. Natural killer cell number and activity in remission phase of systemic connective tissue diseases
42. Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls
43. Natural cell mediated cytotoxicity in systemic lupus erythematosus: Suppression by antilymphocyte antibody
44. Natural killing activity in Sjögren's syndrome. An analysis of defective mechanisms
45. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome
46. Natural killer cell activity in multiple sclerosis and myasthenia gravis
47. Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus
48. Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood
49. Natural killer cell function in rheumatoid arthritis
50. Natural killer (NK) cells at inflammatory sites of patients with rheumatoid arthritis and IgM rheumatoid factor positive polyarticular juvenile rheumatoid arthritis
51. Interferon and natural killer cells in systemic lupus erythematosus
52. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers
53. Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus
54. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes
55. Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: A long-term follow-up study
56. Cytotoxic activity in children with insulin-dependent diabetes mellitus
57. Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis studies in monozygotic discordant twins
58. A study of some immunological variables in twins, discordant for multiple sclerosis
59. Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined
60. Insulin therapy corrects NK cells abnormality in type I diabetes mellitus patients
61. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity
62. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
63. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice
64. The NOD mouse
65. The NOD mouse as a model of SLE
66. High hepatic natural killer cell activity in murine lupus
67. Enhanced natural but diminished antibody-mediated cytotoxicity in the lungs of MRLlpr/lpr mice
68. Morphologic-histochemical characterization of inflammatory cells in insulitis induced by multiple subdiabetogenic doses of streptozotocin in C57131/KsJ mice
69. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings
70. Exogenously-induced, natural killer cell-mediated neuronal killing: A novel pathogenetic mechanism
71. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis
72. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus
73. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice
74. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice
75. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: Evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms
76. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 × DBA/2), F1 hybrid mice injected with DBA/2 spleen cells
77. Post-thymectomy murine experimental autoimmune oophoritis is associated with reduced natural killer cell activity
78. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
79. + T cells in a transfer model of colitis
80. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: Implications for autoimmunity
81. Natural killer cells determine the outcome of B cell-mediated autoimmunity
82. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells
83. From infection to autoimmunity
84. Target cell defense prevents the development of diabetes after virus infection
85. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection
86. NK cell functions restrain T cell responses during viral infections
87. Analysis of in situ NK cell responses during viral infection
88. Dendritic cells and the control of immunity
89. Reciprocal control of T helper cell and dendritic cell differentiation
90. Processing and presentation of antigens by dendritic cells: Implications for vaccines
91. Triggering of natural killer cell mediated cytotoxicity by costimulatory molecules
92. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
93. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
94. Reciprocal activating interaction between natural killer cells and dendritic cells
95. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells
96. Dendritic cells in autoimmune diseases
97. Dendritic cells that have interacted with antigen are targets for natural killer cells
98. + cytolytic T cells by suppressing or eliminating dendritic cells
99. Lysis of human monocytes by lymphokine-activated killer cells
100. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)
101. Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells
102. Recognition of autologous dendritic cells by human NK cells
103. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: Participation of both T cells and NK cells in the killing
104. Targeting of human dendritic cells by autologous NK cells
105. The functional significance of epitope spreading and its regulation by co-stimulatory molecules
106. Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesis
107. Modulation of ongoing human immunoglobulin synthesis by natural killer cells
108. Suppression of B cell responses by natural killer cells is mediated through direct effects on T cells
109. Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation
110. Homeostasis of the antibody response: Immunoregulation by NK cells
111. Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: Role of memory B cells and CD5 (+) B cells
112. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice
113. Immune regulation: A critical link between NK cells and CTLs
114. + T and NK cells
115. + T cells, IL-2, and NK cell-derived TGF-beta: Contrasting effects of anti-CD2 and anti-CD3
116. Natural killer cells and autoimmunity
117. Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease
118. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus
119. Natural killer type 2 bias in remission of multiple sclerosis
120. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
121. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
122. In search of the 'missing self': MHC molecules and NK cell recognition
123. Natural killer cells and recognition of MHC class I molecules: New perspectives and challenges in immunology
124. Immune inhibitory receptors
125. Face off - The interplay between activating and inhibitory immune receptors
126. On guard - Activating NK cell receptors
127. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
128. Ligands for natural killer cell receptors: Redundancy or specificity
129. Strategies for target cell recognition by natural killer cells
130. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
131. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity
132. Recruitment and activation of natural killer (NK) cells in viva determined by the target cell phenotype. An adaptive component of NK cell-mediated responses
133. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H
134. Human fetal thymus and bone marrow contain target cells for natural killer cells
135. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression
136. NK cell-mediated lysis of autologous human oligodendrocytes
137. Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro
138. Lymphoid cells of BB/W diabetic rats are cytotoxic to islet beta cells in vitro
139. Spontaneous diabetes mellitus in the bio-breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells
140. Interleukin 2 activates BB/W diabetic rat lymphoid cells cytotoxic to islet cells
141. Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro
142. Cell cycle control of pancreatic beta cell proliferation
143. Genetic and functional relationships between MHC and NK receptor genes
144. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis
145. + T cells
146. Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins
147. Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells
148. null T cells clonally expanded in rheumatoid arthritis
149. Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis
150. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway
151. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)
152. Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression
153. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules
154. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes
155. Polymorphism in the transmembrane region of the MICA gene and type 1 diabetes
156. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus
157. MICA polymorphism is associated with type 1 diabetes in the Korean population
158. Two distinct MICA gene markers discriminate major autoimmune diabetes types
159. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins
160. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin
161. T-celldependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin
162. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome
163. Rubella infection and diabetes mellitus
164. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome
165. Molecular aspects of myocarditis
166. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death. Learning from the past for the future
167. The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons
168. Negative regulators of cytokine signaling